Close
American Drug Delivery & Formulation Summit
Xylem

Chinese Drug Development Fund Gets $500mn Boost In Hong Kong

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

TRT Safety: What Current Research Actually Says About Long-Term Use

Testosterone replacement therapy has spent years caught between two...

Merck Signs Voluntary Licensing Deals for Oral HIV Pill

Merck has entered into seven voluntary licensing agreements with...

Trump Proposes Generic Drug Tariffs to Drive Reshoring Effort

President Donald Trump announced plans to implement massive generic...
- Advertisement -

The Hong Kong government announced plans to add $500 million to the Chinese Medicine Development Fund beginning with this fiscal year during a budget speech in order to support the commissioning of large-scale training, research, and publicity projects on strategic themes and to advance more capacity-building programmes for the sector, including making preparations for Hong Kong’s first Chinese medicine hospital, which is expected to commence its operations in 2025, and thereby strengthen the Chinese medicine role when it comes to the primary healthcare system.

Several varied practitioners as well as organizations involved in the Chinese medicine industry have benefited from the rollout of more than ten funding schemes since the Chinese Medicine Development Fund’s formal launch in 2019.

It is well to be noted that at the end of the previous year, the government unveiled the Primary Healthcare Blueprint, which outlines several crucial reform initiatives for enhancing Hong Kong’s primary healthcare services and adopts prevention-oriented, community-based, family-centered, as well as early detection and intervention strategies. The goal of the Blueprint is to improve the general public’s health by developing a sustainable healthcare system and offering comprehensive and coordinated healthcare services.

Apparently, as introduced in the Blueprint, the government will launch the Chronic Disease Co-Care Pilot Scheme and enhance measures to the Elderly Health Care Voucher Scheme. The government is most likely to announce the details in the third quarter of 2023 and reserve enough financial resources for the schemes.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Latest stories

Related stories

TRT Safety: What Current Research Actually Says About Long-Term Use

Testosterone replacement therapy has spent years caught between two...

Merck Signs Voluntary Licensing Deals for Oral HIV Pill

Merck has entered into seven voluntary licensing agreements with...

Trump Proposes Generic Drug Tariffs to Drive Reshoring Effort

President Donald Trump announced plans to implement massive generic...

Polymer Science Advancing Sustained Drug Delivery

The development of sustained-release drug delivery systems has transformed...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป